8-K - ZIVO Bioscience, Inc. | StockGist

Current Report Details

Event Type

Regulation Fd

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

7.01

Regulation FD Disclosure. Zivo Bioscience, Inc. (the “Company”) today issued a press release containing a letter to shareholders from CEO John Payne. A copy of

Regulation Fd

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release dated September 10, 2025 104 Cover Page Interactive Data File (embedd

Exhibits Only

Source Document

Exhibits (2)

8-K

FORM 8-K

99.1

PRESS RELEASE